FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: A pharmacological study

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 845-854

  Griffin, B W ^a   Williams, G W ^a   Crider, J Y ^a   Sharif, N A ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; CLOPROSTENOL; FLUPROSTENOL; ILOPROST; INOSITOL PHOSPHATE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 ALPHA DERIVATIVE; PROSTAGLANDIN RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CATTLE; CELL STRAIN 3T3; CONTROLLED STUDY; CORPUS LUTEUM; DRUG RECEPTOR BINDING; MOUSE; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; CALCIUM; DIBENZ(B,F)(1,4)OXAZEPINE-10(11H)-CARBOXYLIC ACID, 8-CHLORO-, 2-ACETYLHYDRAZIDE; HYDANTOINS; INOSITOL PHOSPHATES; MICE; PROSTAGLANDIN ANTAGONISTS; PROTEIN BINDING; RECEPTORS, PROSTAGLANDIN; XANTHENES; XANTHONES;

EID: 0030926442     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. ABRAMOVITZ, M., BOIE, Y., NGUYEN, T., RUSHMORE, T. H., BAYNE, M. A., METTERS, K. M., SLIPETZ, D. M. AND GRYGORCZYK, R.: Cloning and expression of a cDNA for the human prostanoid FP receptor. J. Biol. Chem. 269: 2632-2636, 1994.
2. BECKMANN, M. L., GERBER, J. G., BYYNY, R. L., LOVERDE, M. AND NIES, A. S.: Propranolol increases prostacyclin synthesis in patients with essential hypertension. Hypertension 12: 582-588, 1988.
3. BERRIDGE, M. J., DOWNES, C. P. AND HANLEY, M. R.: Lithium amplifies agonistdependent phosphatidylinositol responses in brain and salivary gland. Biochem. J. 206: 587-595, 1982.
4. BITO, L. Z., DRAGO, A., BLANCO, J. AND CAMRAS, C. B.: Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of PGs to cat and monkey eyes. Invest. Ophthalmol. Vis. Sci. 24: 312-319, 1983.
5. BLEASDALE, J. E., THAKUR, N. R., GREMBAN, R. S., BUNDY, G. L., FITZPATRICK, F. A., SMITH, R. J. AND BUNTING, S.: Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J. Pharmacol. Exp. Ther. 255: 756-768, 1990.
6. BOIE, Y., SAWYER, N., SLIPETZ, D. M., METTERS, K. M. AND ABRAMOVITZ, M.: Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem. 270: 18910-18916, 1995.
7. CHEN, J., CHAMPA-RODRIGUEZ, M. L. AND WOODWARD, D. F.: Identification of a prostanoid FP receptor population producing endothelium-dependent vasorelaxation in the rabbit jugular vein. Br. J. Pharmacol. 116: 3035-3041, 1995.
8. COLEMAN, R. A.: Methods in prostaglandin receptor classification. In PGs and Related Substances: A Practical Approach, ed. by C. Benedetto, R. G. McDonald-Gibson, S. Nigam and T. F. Slater, pp. 267-303, IRL Press, Oxford, UK, 1987.
9. 2 on some isolated smooth muscle preparations. Br. J. Pharmacol. 73: 773-778, 1981.
10. COLEMAN, R. A., KENNEDY, I., HUMPHREY, P. P. A., BUNCE, K. AND LUMLEY, P.: Prostanoids and their receptors. In Comprehensive Medicinal Chemistry, vol. 3, Membranes and Receptors, ed. by J. C. Emmett, pp. 643-714, Pergamon Press, Oxford, UK, 1990.
11. COLEMAN, R. A., SMITH, W. L. AND NARUMIYA, S.: International Union of Pharmacology classification of prostanoid receptors. VIII. Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229, 1994.
12. CORPS, A. N., CHEEK, T. R., MORETON, R. B., BERRIDGE, M. J. AND BROWN, K. D.: Single-cell analysis of the mitogen-induced calcium responses of normal and protein kinase C-depleted Swiss 3T3 cells. Cell Regul. 1: 75-86, 1989.
13. 2+ in bovine luteal cells. Proc. Natl. Acad. Sci. U.S.A. 84: 3728-3732, 1987.
14. DIMARZO, V.: Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. Prostaglandins Leukotrienes Essential Fatty Acids 53: 239-254, 1995.
15. DIMARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.-C. AND PIOMELLI, D.: Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (Lond.) 372: 686-691, 1994.
16. 2α from the ovine corpus luteum. Endocrinology 136: 3430-3436, 1995.
17. GRIFFIN, B. W., WILLIAMS, G. W., CRIDER, J. Y., MAGNINO, P., PANG, I.-H., DESANTIS, L. M. AND SHARIF, N. A.: Receptor affinities and agonist potencies of FP-class prostaglandins. FASEB J. 9: A112, 1995.
18. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
19. 2α receptor. FEES Lett. 355: 317-325, 1994.
20. LANEUVILLE, O., BREUER, D. K., DEWITT, D. L., HLA, T., FUNK, C. D. AND SMITH, W. L.: Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 271: 927-934, 1994.
21. MICHEL, A. D. AND WHITING, R. L.: Analysis of ligand binding data using a microcomputer. Br. J. Pharmacol. 83: 460P, 1984.
22. MITCHELL, J. A., BELVISI, M. G., AKARASEREENONT, P., ROBBINS, R. A., KWON, O.-J., CROXTALL, J., BARNES, P. J. AND VANE, J. R.: Induction of cyclooxygenase-2 by cytokines in human pulmonary epithelial cells: Regulation by dexamethasone. Br. J. Pharmacol. 113: 1008-1014, 1994.
23. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free-radical catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 87: 9383-9387, 1990.
24. 2α can be modulated by fluoride in 3T3-L1 fibroblasts. Biochem. J. 272: 167-174, 1990.
25. 2α receptor of mouse 3T3 fibroblasts and its functional expression in Xenopus laevis oocytes. J. Cell. Physiol. 155: 257-264, 1993.
26. NAMBA, T., OIDA, H., SUGIMOTO, Y., KAKIZUKA, A., NEGISHI, M., ICHIKAWA, A. AND NARUMIYA, S.: cDNA cloning of the mouse prostacyclin receptor. J. Biol. Chem. 269: 9986-9992, 1994.
27. NARUMIYA, S.: Prostanoid receptors: Structure, function, and distribution. In Cellular Generation, Transport, and Effects of Eicosanoids: Biological Roles and Pharmacological Intervention, ed. by E. J. Goetzl, R. A. Lewis and M. Rola-Pleszczynski, pp. 126-138, The New York Academy of Sciences, New York, 1994.
28. S through interaction of α-carboxylic acid of agonist and arginine residue of seventh transmembrane domain. J. Biol. Chem. 270: 16122-16127, 1995.
29. 3 subtype with guanine nucleotide-binding proteins, showing low-affinity ligand binding. Biochim. Biophys. Acta 1175: 343-350, 1993.
30. 2α receptor in bovine corpus luteum plasma membranes. Eur. J. Biochem. 61: 605-611, 1976.
31. 2α receptor. J. Biol. Chem. 269: 3881-3886, 1994.
32. SHARIF, N. A., CRIDER, J. Y., GRIFFIN, B. W., DAVIS, T. L. AND HOWE, W. E.: Pharmacological analysis of mast cell mediator receptors coupled to adenylate cyclase and phospholipase C on immunocytochemically-defined human conjunctival epithelial cells. J. Ocular Pharmacol. Ther., in press, 1997.
33. 3H]GR65630 binding. Br. J. Pharmacol. 102: 919-925, 1991.
34. SHARIF, N. A., Xu, S. X., MILLER, S. T., GAMACHE, D. A. AND YANNI, J. M.: Characterization of the ocular anti-allergic and anti-histaminic effects of olopatadine (AL-4943A). a novel drug for treating ocular allergic diseases. J. Pharmacol. Exp. Ther. 278: 1252-1261, 1996.
35. 1selective antagonist for ocular use: Receptor binding and second messenger studies. J. Ocular Pharmacol. 10: 653-664, 1994.
36. 2 in primary cultures of bovine adrenal medullary cells: Identification of the responsive population as fibroblasts. Biochim. Biophys. Acta 1011: 5-80, 1989.
37. SUGIMOTO, Y., HASUMOTO, K.-Y., NAMBA, T., IRIE, A., KATSUYAMA, M., NEGISHI, M., KAKIZUKA, A., NARUMIYA, S. AND ICHIKAWA, A.: Cloning and expression of a cDNA for mouse prostaglandin F receptor. J. Biol. Chem. 269: 1356-1360, 1994.
38. TAKUWA, N., TAKUWA, Y., YANAGISAWA, M., YAMASHITA, K. AND MASAKI, T.: A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J. Biol. Chem. 264: 7856-7861, 1989.
39. 2, and their esters in glaucomatous monkey eyes. Invest. Ophthalmol. Vis. Sci. 31: 2466-2470, 1990.
40. 2+ transients evoked by prostanoids in Swiss 3T3 cells suggest an FP-receptor mediated response. Adv. Prostaglandin, Thromboxane, Leukotriene Res. 21: 367-370, 1990.
41. WOODWARD, D. F., FAIRBAIRN, C. E., KRAUSS, A. H.-P., LAWRENCE, R. A. AND PROTZMAN, C. E.: Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins. J. Pharmacol. Exp. Ther. 273: 285-291, 1995.
42. 2+ signals in Swiss 3T3 cells. Biochem. Pharmacol. 47: 1567-1574, 1994.
43. YAMAGUCHI, D. T., HAHN, T. J., BEEKER, T. G., KLEEMAN, C. R. AND MUALLEM, S.: Relationship of cAMP and calcium messenger systems in prostaglandin-stimulated UMR-106 cells. J. Biol. Chem. 263: 10745-10753, 1988.